NP90425 Faricimab (Vabysmo(r))

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-r6ebe6-0000821053-2026-02-11T00:00:00Z",
    "date": "2026-02-11T00:00:00Z",
    "ocid": "ocds-r6ebe6-0000821053",
    "initiationType": "tender",
    "parties": [
        {
            "id": "org-10",
            "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)",
            "identifier": {
                "legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)"
            },
            "address": {
                "streetAddress": "1 South Gyle Crescent",
                "locality": "Edinburgh",
                "region": "UKM",
                "postalCode": "EH12 9EB"
            },
            "contactPoint": {
                "email": "megan.rooney@nhs.scot",
                "telephone": "+44 7391479298",
                "url": "http://"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "classifications": [
                    {
                        "id": "Body governed by public law",
                        "scheme": "TED_CA_TYPE"
                    },
                    {
                        "id": "07",
                        "description": "Health",
                        "scheme": "COFOG"
                    }
                ],
                "url": "http://www.nss.nhs.scot/browse/procurement-and-logistics"
            }
        },
        {
            "id": "org-11",
            "name": "Roche Products Ltd",
            "identifier": {
                "legalName": "Roche Products Ltd"
            },
            "address": {
                "streetAddress": "6 Falcon Way, Shire Park",
                "locality": "Welwyn Garden City",
                "region": "UK",
                "postalCode": "AL7 1TW"
            },
            "contactPoint": {
                "telephone": "+44 1707366171"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "large",
                "url": "http://"
            }
        },
        {
            "id": "org-12",
            "name": "Sheriff Court House",
            "identifier": {
                "legalName": "Sheriff Court House"
            },
            "address": {
                "streetAddress": "27 Chambers Street",
                "locality": "Edinburgh",
                "postalCode": "EH1 1LB"
            },
            "contactPoint": {
                "email": "edinburgh@scotcourts.gov.uk",
                "telephone": "+44 1312252525",
                "url": "http://"
            },
            "roles": [
                "reviewBody"
            ]
        }
    ],
    "buyer": {
        "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)",
        "id": "org-10"
    },
    "tender": {
        "id": "ocds-r6ebe6-0000821053",
        "title": "NP90425 Faricimab (Vabysmo(r))",
        "description": "Supply of Faricimab (Vabysmo(r)) to NHSScotland.",
        "status": "complete",
        "items": [
            {
                "id": "1",
                "additionalClassifications": [
                    {
                        "id": "33600000",
                        "scheme": "CPV"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UKM"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "procurementMethod": "limited",
        "procurementMethodDetails": "Award procedure without prior publication of a call for competition",
        "procurementMethodRationale": "The medicine to be awarded to the framework agreement is protected by exclusive rights, including intellectual property rights, in line with Regulation 33(1)(b)(iii) of the Public Contracts (Scotland) Regulations 2015.",
        "mainProcurementCategory": "goods",
        "documents": [
            {
                "id": "FEB549349",
                "documentType": "awardNotice",
                "title": "NP90425 Faricimab (Vabysmo(r))",
                "description": "Supply of Faricimab (Vabysmo(r)) to NHSScotland.",
                "url": "https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=FEB549349",
                "format": "text/html"
            }
        ],
        "lots": [
            {
                "id": "1",
                "description": "The Framework Agreement is for the supply of Faricimab (Vabysmo(r)) to NHSScotland. The Framework Agreement has been awarded as a single supplier framework agreement to one (1) Framework Participant.",
                "status": "complete",
                "hasOptions": false
            }
        ],
        "coveredBy": [
            "GPA"
        ],
        "procurementMethodRationaleClassifications": [
            {
                "id": "D_PROTECT_RIGHTS",
                "description": "The works, supplies or services can be provided only by a particular economic operator due to protection of exclusive rights, including intellectual property rights",
                "scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL"
            }
        ],
        "techniques": {
            "hasFrameworkAgreement": true
        },
        "classification": {
            "id": "33600000",
            "scheme": "CPV"
        },
        "reviewDetails": "The notification will incorporate a 'standstill period' of a minimum of 10 clear calendar days (or a minimum of 15 if the communication method used is not electronic) between the date on which the Authority despatches the VEAT notice and the date on which the Authority proposes to conclude the relevant framework agreement. The bringing of court proceedings against the authority during the standstill period will automatically continue the prohibition on entering into the framework agreement until the court proceedings are determined, discontinued or disposed of, or the court, by interim order, brings to an end the prohibition. The remedies that may be awarded by the courts before the framework agreement has been entered into include the setting aside of the decision to award the framework agreement to the winning tenderer. The bringing of court proceedings against the authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages",
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        }
    },
    "awards": [
        {
            "id": "NP90425",
            "suppliers": [
                {
                    "id": "org-11",
                    "name": "Roche Products Ltd"
                }
            ],
            "relatedLots": [
                "1"
            ]
        }
    ],
    "contracts": [
        {
            "id": "NP90425",
            "awardID": "NP90425",
            "status": "active",
            "value": {
                "amount": 48357375,
                "currency": "GBP"
            },
            "dateSigned": "2026-02-11T00:00:00Z"
        }
    ],
    "language": "EN",
    "description": "The estimated value of the Framework Agreement referred to in Section V.2.4 covers the nine (9) month contract duration and the three (3) x twelve (12) month extension periods of the Framework Agreement. (SC Ref:821053)",
    "links": [
        {
            "rel": "canonical",
            "href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000821053"
        }
    ],
    "noticetype": "OJEU - F15 - Voluntary Ex Ante Transparency Notice"
}